Replies to post #317507 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Very nice:

The trial found that ANAVEX 2-73 activated the sigma-1 receptor, helping to restore neural cell homeostasis (a stable, relatively constant internal environment) and promoting neuroplasticity, the ability of nerve networks to adapt through growth and reorganization. Rett syndrome affects the development of the brain, and according to the National Organization for Rare Disorders, Rett syndrome occurs almost exclusively in girls, affecting one in 10,000 by age 12. ANAVEX 2-73 has the potential to be the first therapy approved for Rett syndrome by the FDA. The drug has already been given Fast Track designation, Rare Pediatric Disease designation, and Orphan Drug designation from the FDA for the treatment of Rett syndrome, so it could be considered for accelerated approval, the company said, meaning that it could come to the market later this year.

https://www.fool.com/investing/2021/06/26/3-top-biotech-stocks-to-buy-right-now/

[plexrec]

Elsa--"Anavex has a potential blockbuster"--great find--thanks for posting--I see the article just came out (Sat.Morning)--nice to get this mention!! Coming out "from under the radar--being noticed--very good " !!!!! Now for that PR this coming week !! Bingo !!

[tredenwater2]

Someone has gotten the “nod” to start covering our company. More and more we are making the presses these days now that our “phase 2” trials are coming out with results. If I remember correctly Biib’s first bluesky run up was on a ph 1 b. To each their own I guess, its allowed me to pick up enough shares over time to be comfortable should approval come from Rett Syndrome, Parkinsons, or Alzheimer’s.

[Ortiz]

Nice. “FOOLS” team is loaded and now it’s time to let it run.